{
    "code": "52027087",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027087",
    "time": "2019-01-11 03:05:39",
    "許可證字號": "衛部藥輸字第027087號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/06\/30",
    "發證日期": "106\/06\/30",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202708706",
    "中文品名": "諾倍適乾粉注射劑",
    "英文品名": "Zerbaxa for Injection",
    "適應症": "治療成人對ceftolozane及tazobactam有感受性的致病菌所引起之複雜性泌尿道感染，包括腎盂腎炎。",
    "劑型": "240乾粉注射劑",
    "包裝": "1.5g玻璃小瓶裝 1-100支盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "CeftolozaneSulfate,TAZOBACTAM(ASSODIUM)"
    ],
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "0929301100  美商默沙東藥廠股份有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F460916000  Steri-Pharma, LLC",
        "製造廠廠址": "429 S. West Street, Syracuse, NY 13202 USA",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812310300",
            "成分名稱": "Ceftolozane Sulfate",
            "含量描述": "(eq to Ceftolozane.........1000mg)",
            "含量": "1147.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4410000710",
            "成分名稱": "TAZOBACTAM (AS SODIUM)",
            "含量描述": "(eq to Tazobactam.........500mg)",
            "含量": "537.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020270870001-106-07-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027087&Seq=001&Type=9"
        },
        {
            "title": "020270870001-106-07-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027087&Seq=002&Type=8"
        },
        {
            "title": "020270870001-106-07-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027087&Seq=001&Type=8"
        }
    ]
}